1539 related articles for article (PubMed ID: 25369127)
1. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
Ma DL; Chan DS; Leung CH
Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
[TBL] [Abstract][Full Text] [Related]
2. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes.
Leung SK; Kwok KY; Zhang KY; Lo KK
Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281
[TBL] [Abstract][Full Text] [Related]
3. Antagonizing STAT3 dimerization with a rhodium(III) complex.
Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
[TBL] [Abstract][Full Text] [Related]
4. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
Lee PK; Law WH; Liu HW; Lo KK
Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
[TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.
Hisamatsu Y; Shibuya A; Suzuki N; Suzuki T; Abe R; Aoki S
Bioconjug Chem; 2015 May; 26(5):857-79. PubMed ID: 25875312
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
[TBL] [Abstract][Full Text] [Related]
7. Luminescent dendritic cyclometalated iridium(III) polypyridine complexes: synthesis, emission behavior, and biological properties.
Zhang KY; Liu HW; Fong TT; Chen XG; Lo KK
Inorg Chem; 2010 Jun; 49(12):5432-43. PubMed ID: 20491455
[TBL] [Abstract][Full Text] [Related]
8. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
Almodares Z; Lucas SJ; Crossley BD; Basri AM; Pask CM; Hebden AJ; Phillips RM; McGowan PC
Inorg Chem; 2014 Jan; 53(2):727-36. PubMed ID: 24397747
[TBL] [Abstract][Full Text] [Related]
9. Half-sandwich iridium- and rhodium-based organometallic architectures: rational design, synthesis, characterization, and applications.
Han YF; Jin GX
Acc Chem Res; 2014 Dec; 47(12):3571-9. PubMed ID: 25419985
[TBL] [Abstract][Full Text] [Related]
10. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
11. Organoiridium complexes: anticancer agents and catalysts.
Liu Z; Sadler PJ
Acc Chem Res; 2014 Apr; 47(4):1174-85. PubMed ID: 24555658
[TBL] [Abstract][Full Text] [Related]
12. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.
Ruiz J; Rodríguez V; Cutillas N; Samper KG; Capdevila M; Palacios Ò; Espinosa A
Dalton Trans; 2012 Nov; 41(41):12847-56. PubMed ID: 22983366
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.
Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS
Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555
[TBL] [Abstract][Full Text] [Related]
14. Cationic bis-cyclometallated iridium(III) phenanthroline complexes with pendant fluorenyl substituents: synthesis, redox, photophysical properties and light-emitting cells.
Zeng X; Tavasli M; Perepichka IF; Batsanov AS; Bryce MR; Chiang CJ; Rothe C; Monkman AP
Chemistry; 2008; 14(3):933-43. PubMed ID: 18033698
[TBL] [Abstract][Full Text] [Related]
15. Impact of various lipophilic substituents on ruthenium(II), rhodium(III) and iridium(III) salicylaldimine-based complexes: synthesis, in vitro cytotoxicity studies and DNA interactions.
Cassells I; Stringer T; Hutton AT; Prince S; Smith GS
J Biol Inorg Chem; 2018 Jul; 23(5):763-774. PubMed ID: 29846816
[TBL] [Abstract][Full Text] [Related]
16. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
[TBL] [Abstract][Full Text] [Related]
17. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
Yellol J; Pérez SA; Yellol G; Zajac J; Donaire A; Vigueras G; Novohradsky V; Janiak C; Brabec V; Ruiz J
Chem Commun (Camb); 2016 Dec; 52(98):14165-14168. PubMed ID: 27869279
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structural characterization of binuclear half-sandwich iridium, rhodium and ruthenium complexes containing 4,4'-dipyridyldisulfide (4DPDS) ligands.
Han YF; Li H; Fei Y; Lin YJ; Zhang WZ; Jin GX
Dalton Trans; 2010 Aug; 39(30):7119-24. PubMed ID: 20593103
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
20. Water reduction systems associated with homoleptic cyclometalated iridium complexes of various 2-phenylpyridines.
Yuan YJ; Yu ZT; Cai JG; Zheng C; Huang W; Zou ZG
ChemSusChem; 2013 Aug; 6(8):1357-65. PubMed ID: 23843363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
